Mary E. Edgerton

Proteomic patterns of tumour subsets in non-small-cell lung cancer

Kiyoshi Yanagisawa, Yu Shyr, Baogang Xu et al. · The Lancet · 2003 · 598 citations

Tumor Biology, Tumour Subsets, Tumor Heterogeneity +6

Multiclonal Invasion in Breast Tumors Identified by Topographic Single Cell Sequencing

Aislyn Schalck, Ruli Gao, Emi Sei et al. · Cell · 2018 · 425 citations · Full text

Breast Oncology, Oncology, Tumor Heterogeneity +14

Significance of p63 amplification and overexpression in lung cancer development and prognosis.

Pierre P. Massion, Peter M. Taflan, S.M. Jamshedur Rahman et al. · PubMed · 2003 · 321 citations

Lung Cancer Progression, Pathology, Cancer Biology +16

Patient-calibrated agent-based modelling of ductal carcinoma in situ (DCIS): From microscopic measurements to macroscopic predictions of clinical progression

Paul Macklin, Mary E. Edgerton, Alastair M. Thompson et al. · Journal of Theoretical Biology · 2012 · 240 citations · Full text

Tumor Biology, Microscopic Measurements, Cancer Detection +12

The Pan-Cancer analysis of pseudogene expression reveals biologically and clinically relevant tumour subtypes

Leng Han, Yuan Yuan, Siyuan Zheng et al. · Nature Communications · 2014 · 185 citations · Full text

Tumor Biology, Oncology, Malignant Disease +12